Seysara
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
16110-247 -
Package NDC
16110-247-30 -
Application number
NDA209521 -
SPL ID
4f9be4df-4e12-4f08-8e6f-cb07926ea5e6 -
SPL set ID
b200957c-3004-4988-be97-9fd619a83649 -
UNII
36718856JR -
RxCUI
2059023 -
RxCUI
2059029 -
RxCUI
2059031 -
RxCUI
2059033 -
RxCUI
2059035 -
RxCUI
2059037
What the source publishes
- Labeler
- Almirall, LLC
- Active ingredients
- sarecycline hydrochloride
- Form
- TABLET, COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Seysara",
"splId": "4f9be4df-4e12-4f08-8e6f-cb07926ea5e6",
"labels": [
{
"setId": "b200957c-3004-4988-be97-9fd619a83649",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b200957c-3004-4988-be97-9fd619a83649",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b200957c-3004-4988-be97-9fd619a83649"
}
],
"routes": [
"ORAL"
],
"labeler": "Almirall, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, COATED in 1 BOTTLE (16110-247-30)",
"package_ndc": "16110-247-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20190104"
}
],
"productId": "16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6",
"useDomain": "unknown",
"dosageForm": "TABLET, COATED",
"productNdc": "16110-247",
"deaSchedule": null,
"genericName": "sarecycline hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SARECYCLINE HYDROCHLORIDE",
"strength": "150 mg/1"
}
],
"applicationNumber": "NDA209521",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190104",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0316110245300",
"0316110246307"
],
"unii": [
"36718856JR"
],
"rxcui": [
"2059023",
"2059029",
"2059031",
"2059033",
"2059035",
"2059037"
],
"spl_set_id": [
"b200957c-3004-4988-be97-9fd619a83649"
],
"manufacturer_name": [
"Almirall, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6"